ADJACENT TREATMENT

Caffeine

A methylxanthine stimulant included here as a disclosed combination ingredient, not as a peptide or a standalone treatment recommendation.

Record boundary

Type: Methylxanthine stimulant
Category: Other
Status: Editorial review pending

On this page

01 / CLASSIFICATION

Not every wellness-market record is a peptide.

Caffeine is included because it appears in the source inventory, but it is classified as methylxanthine stimulant. This prevents search coverage from distorting the underlying science.

Coverage is not endorsement

This page confirms that the item exists in the coverage graph. It does not recommend use or repeat commercial benefit claims.

02 / SOURCES

Inspect the record trail.

IDENTITY SOURCEPubChem compound record

Primary or authoritative identity record

COVERAGE SOURCEBB Health+ tadalafil combination offering

Source inventory reviewed August 8, 2026

03 / REVIEW BOUNDARY

What is still intentionally unresolved.

Evidence

No evidence score is shown until human and preclinical sources are reviewed separately.

Status

No approval, compounding, or anti-doping statement is inherited from a related ingredient without review.